Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital

@inproceedings{Umpierrez2018DiabetesTU,
  title={Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital},
  author={Guillermo E Umpierrez and David C. Klonoff},
  booktitle={Diabetes care},
  year={2018}
}
The use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems has gained wide acceptance in diabetes care. These devices have been demonstrated to be clinically valuable, improving glycemic control and reducing risks of hypoglycemia in ambulatory patients with type 1 diabetes and type 2 diabetes. Approximately 30-40% of patients with type 1 diabetes and an increasing number of insulin-requiring patients with type 2 diabetes are using pump and sensor… CONTINUE READING
5
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 103 REFERENCES

Consensus Statement on Inpatient Use of Continuous Glucose Monitoring.

  • Journal of diabetes science and technology
  • 2017
VIEW 20 EXCERPTS
HIGHLY INFLUENTIAL

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

  • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2009
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Hypoglycemia in Type 1 Diabetes Mellitus

  • Treatments in endocrinology
  • 2004
VIEW 14 EXCERPTS
HIGHLY INFLUENTIAL

Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings.

  • Diabetic medicine : a journal of the British Diabetic Association
  • 2018
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL